Moderna aims to deliver 1 billion more vaccine doses to low-income countries in 2022 By Reuters
[ad_1]
© Reuters. FILEPHOTO: This illustration was taken on May 21st, 2021. It shows test tubes in front of the Moderna logo. REUTERS/Dado Ruvic/Illustration(Reuters). Moderna Inc stated Friday that one million doses of COVID-19 vaccine will be delivered to low-income countries by 2022. This is in addition to what it has already pledged to the COVAX global vaccine-sharing platform.
They will form part of approximately 2-3 billion vaccines produced by the company next year.
Globally, over 250 million people have received the vaccine to date. Moderna (NASDAQ:) COVID-19 vaccine. However, we recognize that access to vaccines continues to be a challenge in many parts of the world,” Chief Executive Officer Stéphane Bancel said in a letter https://investors.modernatx.com/news-releases/news-release-details/our-global-commitment-vaccine-access posted on the company’s website.
Moderna, announced on Thursday plans to invest as much as $500 million to construct a factory to manufacture up to 500 million doses mRNA vaccinations in Africa each year.
Company had previously committed, in May, to supply as many as 500 million doses COVID-19 to COVAX from the fourth quarter to 2022.
Bancel declared, “We have committed to increasing our production and expanding our supply until our vaccine no longer needs in low-income nations.”
Fusion MediaFusion Media or any other person involved in the website will not be held responsible for any loss or damage resulting from reliance on this information, including charts, buy/sell signals, and data. Trading the financial markets is one of most risky investment options. Please make sure you are fully aware about the costs and risks involved.
[ad_2]
